US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist

3.580
+0.230+6.87%

Close Nov 1 16:00 ET

3.450
-0.130-3.63%

Post 20:02 ET

151.96MMarket Cap-2196P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

11.16%-30.51M

137.54%11.93M

-39,590.06%-127.16M

5.00%-28.16M

-137.29%-32.87M

-21.82%-34.35M

-5.93%-31.79M

100.38%322K

-42.91%-29.64M

369.00%88.16M

Net income from continuing operations

-191.09%-34.77M

137.67%13.16M

-222.91%-93.8M

11.46%-28.03M

-125.02%-18.88M

68.64%-11.95M

-0.53%-34.94M

72.83%-29.05M

-11.91%-31.66M

344.27%75.46M

Operating gains losses

16.67%-5K

-133.33%-22K

126.17%78K

110.29%7K

111.70%11K

93.75%-6K

265.00%66K

-927.78%-298K

-361.54%-68K

-508.70%-94K

Depreciation and amortization

-3.56%488K

13.61%501K

-1.37%1.95M

11.21%506K

2.89%498K

-3.25%506K

-14.53%441K

34.47%1.98M

23.64%455K

31.17%484K

Deferred tax

----

-55.03%-1.25M

Other non cash items

4.22%568K

4.07%563K

-0.54%2.19M

-1.07%557K

-0.18%551K

-0.37%545K

-0.55%541K

17.78%2.21M

-9.92%563K

10.40%552K

Change In working capital

94.04%-1.65M

-254.54%-7.5M

-787.64%-55.18M

8.17%-5.9M

-324.24%-19.55M

-605.69%-27.62M

-883.70%-2.12M

67.54%8.03M

-645.33%-6.42M

253.14%8.72M

-Change in receivables

159.77%740K

140.50%1.11M

84.40%-216K

-108.23%-775K

143.60%4.54M

-8,353.33%-1.24M

-578.47%-2.74M

-146.20%-1.39M

7,020.59%9.41M

-424.74%-10.41M

-Change in prepaid assets

-1,328.72%-2.31M

-3.31%1.29M

63.41%969K

1,066.27%802K

43.61%-1.35M

-72.07%188K

-44.56%1.33M

1,953.13%593K

-103.47%-83K

66.00%-2.4M

-Change in payables and accrued expense

-47.03%1.58M

3.15%1.47M

-517.87%-9.98M

352.33%5.64M

-22,925.29%-20.03M

-46.94%2.98M

256.69%1.43M

-79.79%2.39M

-132.74%-2.23M

87.71%-87K

-Change in other current assets

--0

0.00%89K

13.48%101K

--1K

--11K

--0

--89K

129.87%89K

--0

-Change in other current liabilities

-5.42%-584K

-6.59%-582K

-45.13%-2.22M

-43.80%-568K

-17.12%-554K

-114.73%-554K

-34.81%-546K

-50.10%-1.53M

-50.76%-395K

-90.73%-473K

-Change in other working capital

96.30%-1.07M

-548.72%-10.88M

-656.95%-43.83M

16.21%-11M

-109.78%-2.16M

-4,170.99%-29M

-311.03%-1.68M

190.66%7.87M

-64.92%-13.12M

8,042.81%22.08M

Cash from discontinued investing activities

Operating cash flow

11.16%-30.51M

137.54%11.93M

-39,590.06%-127.16M

5.00%-28.16M

-137.29%-32.87M

-21.82%-34.35M

-5.93%-31.79M

100.38%322K

-42.91%-29.64M

369.00%88.16M

Investing cash flow

Cash flow from continuing investing activities

-74.89%7.12M

-203.86%-20.32M

144.40%78.04M

-6.40%31.88M

111.73%24.5M

2,265.78%28.35M

-1,759.06%-6.69M

-10,387.95%-175.78M

8,657.29%34.06M

-53,609.51%-208.93M

Net PPE purchase and sale

--0

-221.93%-1.94M

-123.14%-398K

--0

32.12%-1.07M

2.46%-475K

63.52%-602K

1,476.00%1.72M

17.90%-266K

Net investment purchase and sale

-75.80%7.12M

-227.10%-20.32M

145.66%79.98M

-0.19%32.28M

111.74%24.5M

11,213.46%29.42M

-797.87%-6.21M

-673,653.85%-175.18M

11,945.42%32.34M

-320,921.54%-208.66M

Cash from discontinued investing activities

Investing cash flow

-74.89%7.12M

-203.86%-20.32M

144.40%78.04M

-6.40%31.88M

111.73%24.5M

2,265.78%28.35M

-1,759.06%-6.69M

-10,387.95%-175.78M

8,657.29%34.06M

-53,609.51%-208.93M

Financing cash flow

Cash flow from continuing financing activities

-9.20%375K

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-99.08%880K

-99.83%165K

-25.90%269K

Proceeds from stock option exercised by employees

--0

-9.20%375K

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-30.65%880K

-39.78%165K

-25.90%269K

Cash from discontinued financing activities

Financing cash flow

--0

-9.20%375K

-4.32%842K

-36.36%105K

5.58%284K

-80.49%40K

71.37%413K

-99.08%880K

-99.83%165K

-25.90%269K

Net cash flow

Beginning cash position

-15.02%103.22M

-30.25%111.27M

-52.30%159.52M

-30.81%107.37M

-58.11%115.54M

-60.19%121.46M

-52.30%159.52M

2.46%334.43M

-40.54%155.19M

-6.13%275.83M

Current changes in cash

-292.81%-23.4M

78.96%-8.01M

72.35%-48.28M

-16.53%3.83M

93.29%-8.09M

79.67%-5.96M

-29.62%-38.06M

-2,259.26%-174.58M

-93.75%4.59M

-267.40%-120.5M

Effect of exchange rate changes

-102.56%-1K

-4,100.00%-42K

106.67%22K

127.73%71K

37.86%-87K

880.00%39K

-101.41%-1K

-511.11%-330K

-4,366.67%-256K

-137.29%-140K

End cash Position

-30.92%79.82M

-15.02%103.22M

-30.25%111.27M

-30.81%107.37M

-58.11%115.54M

-60.19%121.46M

-52.30%159.52M

-40.54%155.19M

Free cash flow

13.83%-30.51M

136.99%11.93M

-46,005.71%-129.1M

-2.28%-28.55M

-137.40%-32.87M

-18.98%-35.41M

-5.80%-32.26M

99.68%-280K

-33.55%-27.92M

365.56%87.89M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	11.16%-30.51M	137.54%11.93M	-39,590.06%-127.16M	5.00%-28.16M	-137.29%-32.87M	-21.82%-34.35M	-5.93%-31.79M	100.38%322K	-42.91%-29.64M	369.00%88.16M
Net income from continuing operations	-191.09%-34.77M	137.67%13.16M	-222.91%-93.8M	11.46%-28.03M	-125.02%-18.88M	68.64%-11.95M	-0.53%-34.94M	72.83%-29.05M	-11.91%-31.66M	344.27%75.46M
Operating gains losses	16.67%-5K	-133.33%-22K	126.17%78K	110.29%7K	111.70%11K	93.75%-6K	265.00%66K	-927.78%-298K	-361.54%-68K	-508.70%-94K
Depreciation and amortization	-3.56%488K	13.61%501K	-1.37%1.95M	11.21%506K	2.89%498K	-3.25%506K	-14.53%441K	34.47%1.98M	23.64%455K	31.17%484K
Deferred tax	----	----	----	----	----	----	----	----	----	-55.03%-1.25M
Other non cash items	4.22%568K	4.07%563K	-0.54%2.19M	-1.07%557K	-0.18%551K	-0.37%545K	-0.55%541K	17.78%2.21M	-9.92%563K	10.40%552K
Change In working capital	94.04%-1.65M	-254.54%-7.5M	-787.64%-55.18M	8.17%-5.9M	-324.24%-19.55M	-605.69%-27.62M	-883.70%-2.12M	67.54%8.03M	-645.33%-6.42M	253.14%8.72M
-Change in receivables	159.77%740K	140.50%1.11M	84.40%-216K	-108.23%-775K	143.60%4.54M	-8,353.33%-1.24M	-578.47%-2.74M	-146.20%-1.39M	7,020.59%9.41M	-424.74%-10.41M
-Change in prepaid assets	-1,328.72%-2.31M	-3.31%1.29M	63.41%969K	1,066.27%802K	43.61%-1.35M	-72.07%188K	-44.56%1.33M	1,953.13%593K	-103.47%-83K	66.00%-2.4M
-Change in payables and accrued expense	-47.03%1.58M	3.15%1.47M	-517.87%-9.98M	352.33%5.64M	-22,925.29%-20.03M	-46.94%2.98M	256.69%1.43M	-79.79%2.39M	-132.74%-2.23M	87.71%-87K
-Change in other current assets	--0	0.00%89K	13.48%101K	--1K	--11K	--0	--89K	129.87%89K	--0	--0
-Change in other current liabilities	-5.42%-584K	-6.59%-582K	-45.13%-2.22M	-43.80%-568K	-17.12%-554K	-114.73%-554K	-34.81%-546K	-50.10%-1.53M	-50.76%-395K	-90.73%-473K
-Change in other working capital	96.30%-1.07M	-548.72%-10.88M	-656.95%-43.83M	16.21%-11M	-109.78%-2.16M	-4,170.99%-29M	-311.03%-1.68M	190.66%7.87M	-64.92%-13.12M	8,042.81%22.08M
Cash from discontinued investing activities
Operating cash flow	11.16%-30.51M	137.54%11.93M	-39,590.06%-127.16M	5.00%-28.16M	-137.29%-32.87M	-21.82%-34.35M	-5.93%-31.79M	100.38%322K	-42.91%-29.64M	369.00%88.16M
Investing cash flow
Cash flow from continuing investing activities	-74.89%7.12M	-203.86%-20.32M	144.40%78.04M	-6.40%31.88M	111.73%24.5M	2,265.78%28.35M	-1,759.06%-6.69M	-10,387.95%-175.78M	8,657.29%34.06M	-53,609.51%-208.93M
Net PPE purchase and sale	--0	--0	-221.93%-1.94M	-123.14%-398K	--0	32.12%-1.07M	2.46%-475K	63.52%-602K	1,476.00%1.72M	17.90%-266K
Net investment purchase and sale	-75.80%7.12M	-227.10%-20.32M	145.66%79.98M	-0.19%32.28M	111.74%24.5M	11,213.46%29.42M	-797.87%-6.21M	-673,653.85%-175.18M	11,945.42%32.34M	-320,921.54%-208.66M
Cash from discontinued investing activities
Investing cash flow	-74.89%7.12M	-203.86%-20.32M	144.40%78.04M	-6.40%31.88M	111.73%24.5M	2,265.78%28.35M	-1,759.06%-6.69M	-10,387.95%-175.78M	8,657.29%34.06M	-53,609.51%-208.93M
Financing cash flow
Cash flow from continuing financing activities	0	-9.20%375K	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-99.08%880K	-99.83%165K	-25.90%269K
Proceeds from stock option exercised by employees	--0	-9.20%375K	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-30.65%880K	-39.78%165K	-25.90%269K
Cash from discontinued financing activities
Financing cash flow	--0	-9.20%375K	-4.32%842K	-36.36%105K	5.58%284K	-80.49%40K	71.37%413K	-99.08%880K	-99.83%165K	-25.90%269K
Net cash flow
Beginning cash position	-15.02%103.22M	-30.25%111.27M	-52.30%159.52M	-30.81%107.37M	-58.11%115.54M	-60.19%121.46M	-52.30%159.52M	2.46%334.43M	-40.54%155.19M	-6.13%275.83M
Current changes in cash	-292.81%-23.4M	78.96%-8.01M	72.35%-48.28M	-16.53%3.83M	93.29%-8.09M	79.67%-5.96M	-29.62%-38.06M	-2,259.26%-174.58M	-93.75%4.59M	-267.40%-120.5M
Effect of exchange rate changes	-102.56%-1K	-4,100.00%-42K	106.67%22K	127.73%71K	37.86%-87K	880.00%39K	-101.41%-1K	-511.11%-330K	-4,366.67%-256K	-137.29%-140K
End cash Position	-30.92%79.82M	-15.02%103.22M	-30.25%111.27M	-30.25%111.27M	-30.81%107.37M	-58.11%115.54M	-60.19%121.46M	-52.30%159.52M	-52.30%159.52M	-40.54%155.19M
Free cash flow	13.83%-30.51M	136.99%11.93M	-46,005.71%-129.1M	-2.28%-28.55M	-137.40%-32.87M	-18.98%-35.41M	-5.80%-32.26M	99.68%-280K	-33.55%-27.92M	365.56%87.89M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data